Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy

被引:3
|
作者
Rao, Anirudh [1 ,2 ]
Singh, Manavotam [3 ]
Maini, Mansi [1 ]
Anderson, Kelley M. M. [4 ]
Crowell, Nancy A. A. [4 ]
Henderson, Paul R. R. [1 ]
Gholami, Sherry S. S. [1 ]
Sheikh, Farooq H. H. [1 ,3 ]
Najjar, Samer S. S. [3 ]
Groninger, Hunter [1 ,2 ]
机构
[1] Georgetown Univ, Sch Med, Dept Med, Washington, DC 20007 USA
[2] MedStar Washington Hosp Ctr, Dept Med, Sect Palliat Med, Washington, DC 20010 USA
[3] MedStar Heart & Vasc Inst, MedStar Washington Hosp Ctr, Washington, DC USA
[4] Georgetown Univ, Sch Nursing & Hlth Studies, Washington, DC USA
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词
inotropes; Stage D heart failure; palliative care; LVAD; heart transplant; HEART-FAILURE; FRAILTY; GUIDELINES; CRITERIA; SOCIETY;
D O I
10.3389/fcvm.2022.918146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundMany patients with advanced heart failure (HF) are administered chronic intravenous inotropic support (CIIS) as bridge to surgical therapy; some ultimately never receive surgery. We aimed to describe reasons patients "crossover" from CIIS as bridge therapy to palliative therapy, and compare end-of-life outcomes to patients initiated on CIIS as palliative therapy. MethodsSingle-institution, retrospective cohort study of patients on CIIS as bridge or palliative therapy between 2010 and 2016; data obtained through review of health records and multi-disciplinary selection meeting minutes, was analyzed using descriptive and inferential statistics. ResultsOf 246 patients discharged on CIIS as bridge therapy, 37 (16%) (male n = 28, 76%; African American n = 22, 60%) ultimately never received surgery. 67 matched patients on CIIS as palliative therapy were included for analysis (male n = 47, 70%; African American n = 47, 70%). The most common reasons for "crossover" from CIIS as bridge therapy to palliative therapy were frailty (n = 10, 27%), cardiac arrest (n = 5, 13.5%), and progressive non-cardiac illnesses (n = 6, 16.2%). A similar percentage of patients in the bridge (n = 28, 76%) and palliative (n = 48, 72%) groups died outside the hospital (P=0.66); however, fewer bridge patients received hospice care compared to the palliative group (35% vs 69%, P < 0.001). Comparing patients who died in the hospital, bridge patients (n = 9; 100%) were more likely to die in the intensive care unit than palliative patients (n = 8; 42%) (P < 0.001). ConclusionPatients on CIIS as bridge therapy who do not ultimately receive surgical therapy "crossover" to palliative intention due to frailty, or development of or identification of serious illnesses. Nevertheless, these "bridge to nowhere" patients are less likely to receive palliative care or hospice and more likely to die in the intensive care unit than patients on CIIS as palliative therapy.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Biliary-Pancreatic Endoscopic and Surgical Procedures in Patients under Dual Antiplatelet Therapy: A Single-Center Study
    Samie, Ahmed Abdel
    Stumpf, Michael
    Sun, Rui
    Theilmann, Lorenz
    CLINICAL ENDOSCOPY, 2013, 46 (04) : 395 - 398
  • [42] Surgical Site Complications After Complex Iliofemoral Reconstruction and the Role of Negative Pressure Wound Therapy: A Retrospective, Single-center Study
    Sorour, Ahmed A.
    Kirksey, Levester
    Ambur, Vishnu
    Bena, James
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2022, 34 (04): : E22 - E28
  • [43] The implication of compromised renal function at presentation in myeloma. Similar outcome in patients who receive high-dose therapy: A single-center study of 251 previously untreated patients
    Sirohi B.
    Powles R.
    Mehta J.
    Treleaven J.
    Raje N.
    Kulkarni S.
    Rudin C.
    Bhagwati N.
    Horton C.
    Saso R.
    Singhal S.
    Parikh P.
    Medical Oncology, 2001, 18 (1) : 39 - 50
  • [44] Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study
    Jonsson, Sofia
    Olsson, Bob
    Soderberg, Jenny
    Wadenvik, Hans
    ANNALS OF HEMATOLOGY, 2012, 91 (05) : 679 - 685
  • [45] Erratum to: Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study
    Sofia Jönsson
    Bob Olsson
    Jenny Söderberg
    Hans Wadenvik
    Annals of Hematology, 2017, 96 : 1419 - 1419
  • [46] RITUXIMAB VERSUS ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO PRIOR BIOLOGIC THERAPY: A RETROSPECTIVE SINGLE-CENTER STUDY
    Keystone, E.
    Weber, D.
    Xiong, J.
    Sun, Y.
    Grant, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 449 - 450
  • [47] Rituximab versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective Single-Center Study
    Keystone, Edward
    Weber, Deborah
    Xiong, Juan
    Sun, Ye
    Grant, Alex
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1456 - 1457
  • [48] Incidence of Venous Thromboembolism in Patients with Hematologic Malignancies Receiving Immunomodulators and Concurrent Anticoagulation Therapy: A Single-Center Retrospective Study
    Lee, Irene
    Bodiford, Andrew
    Sion, Amy
    Neppalli, Amarendra K.
    BLOOD, 2017, 130
  • [49] Outcomes among Patients Treated with Renal Replacement Therapy during Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Study
    Dado, David N.
    Ainsworth, Craig R.
    Thomas, Sarah B.
    Huang, Benjamin
    Piper, Lydia C.
    Sams, Valerie G.
    Batchinsky, Andriy
    Morrow, Benjamin D.
    Basel, Anthony P.
    Walter, Robert J.
    Mason, Phillip E.
    Chung, Kevin K.
    BLOOD PURIFICATION, 2020, 49 (03) : 341 - 347
  • [50] Rituximab Versus Abatacept in Rheumatoid Arthritis Patients with an Inadequate Response to Prior Biologic Therapy: A Retrospective, Single-Center Study
    Keystone, Edward
    Xiong, Juan
    Weber, Deborah
    Sun, Ye
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S557 - S557